Zhou Minjie, Yang Mingyue, Chen Lei, Yu Chao, Zhang Wei, Ji Jun, Chen Chi, Shen Xueyong, Ying Jian
Shanghai Qigong Research Institute, Shanghai, China.
Shanghai TCM-INTEGRATED Hospital, Shanghai, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
BMC Complement Altern Med. 2017 May 12;17(1):263. doi: 10.1186/s12906-017-1768-2.
The chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is one of the commonest chronic inflammatory diseases in adult men, for which acupuncture has been used to relieve related symptoms. The present study aimed to evaluate the therapeutic effect of the long-needle acupuncture on CP/CPPS.
A randomized traditional acupuncture-controlled single blind study was conducted on 77 patients who were randomized into long-needle acupuncture (LA) and traditional acupuncture (TA) groups. The patients received six sessions of acupuncture for 2 weeks and a follow-up was scheduled at week 24. The primary outcome was measured by the total National Institutes of Health-Chronic Prostatitis Symptom Index (NIH-CPSI) score at week 2. Four domains of the NIH-CPSI (urination, pain or discomfort, effects of symptoms, and quality of life) and the clinical efficacy score served as the secondary outcome.
The total NIH-CPSI score at week 2 and week 24 was significantly improved in the LA group compared with the TA group. LA significantly improved urination, pain or discomfort, the effects of symptoms, and the quality of life at week 2 and week 24 and patients undergoing LA treatment had a higher clinical efficacy score.
Needling at the BL30 and BL35 using LA benefits patients with CP/CPPS.
The study was registered at the Chinese Clinical Trial Register ( ChiCTR-ICR-15006138 ).
慢性前列腺炎/慢性盆腔疼痛综合征（CP/CPPS）是成年男性中最常见的慢性炎症性疾病之一，针灸已被用于缓解相关症状。本研究旨在评估长针针刺对CP/CPPS的治疗效果。
对77例患者进行了一项随机传统针刺对照单盲研究，这些患者被随机分为长针针刺（LA）组和传统针刺（TA）组。患者接受为期2周的6次针刺治疗，并计划在第24周进行随访。主要结局指标为第2周时美国国立卫生研究院慢性前列腺炎症状指数（NIH-CPSI）总分。NIH-CPSI的四个领域（排尿、疼痛或不适、症状影响和生活质量）以及临床疗效评分作为次要结局指标。
与TA组相比，LA组在第2周和第24周时NIH-CPSI总分显著改善。LA在第2周和第24周时显著改善了排尿、疼痛或不适、症状影响和生活质量，接受LA治疗的患者临床疗效评分更高。
采用长针针刺BL30和BL35穴位对CP/CPPS患者有益。
该研究已在中国临床试验注册中心注册（ChiCTR-ICR-15006138）。
